Jerel A. Banks
2024
In 2024, Jerel A. Banks earned a total compensation of $2.8M as Executive Chairman and Chief Executive Officer at Benitec Biopharma, a 205% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,133,085 |
|---|---|
| Salary | $627,900 |
| Other | $37,992 |
| Total | $2,798,977 |
Banks received $2.1M in option awards, accounting for 76% of the total pay in 2024.
Banks also received $627.9K in salary and $38K in other compensation.
Rankings
In 2024, Jerel A. Banks' compensation ranked 14th out of 207 executives tracked by ExecPay. In other words, Banks earned more than 93.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14 out of 207 | 93rd |
Division Manufacturing | 4 out of 89 | 96th |
Major group Chemicals And Allied Products | 1 out of 36 | 97th |
Industry group Drugs | 1 out of 33 | 97th |
Industry Pharmaceutical Preparations | 1 out of 30 | 97th |
Source: SEC filing on October 23, 2024.
Banks' colleagues
We found one more compensation record of an executive working with Jerel A. Banks at Benitec Biopharma in 2024.
2024
Megan Boston
Benitec Biopharma